Q2 2026 saw 20%+ revenue growth, record profitability, and margin expansion, driven by strong demand and operational discipline. The VitalConnect acquisition will expand cardiac monitoring capabilities and address new market segments, with integration expected to accelerate growth from 2027.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.